chiral molecule

Bayzed operates healthcare

BRIEF: XtalPi acquires British chiral molecule developer

AI drug discovery company XtalPi Holdings Ltd. (2228.HK) said on Thursday it has acquired Liverpool ChiroChem Technologies Ltd. (LCC), a developer of novel molecules specializing in chiral molecules. It did not disclose…
2228.HK

Recent Articles

RELATED ARTICLES

  1. XtalPi deploys artificial intelligence in drug discovery
    NEWS WRAP: Surging Xtalpi seizes on tech rally to raise $267 million
    2228.HK
  2. BRIEF: XtalPi shares surge on Microsoft China partnership
    2228.HK
  3. RNA drug developer Ribo Life targets fresh funding channel
  4. BRIEF: Shein London IPO approved by British financial regulator
  5. Everest Medicines drives growth with AI-powered mRNA pipeline
    1952.HK
  6. BeiGene heads for profit milestone after hemorrhaging cash
    6160.HK ONC.US 688235.SHG
  7. Joinn Labs undermined by AI as FDA phases out animal drug testing
    6127.HK 603127.SHG
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva